Status:
UNKNOWN
Transcriptomal and Molecular Characterization of Tumor Associated Monocytes/Macrophages in Human Cancers
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Tumor
Cancer
Eligibility:
All Genders
21+ years
Brief Summary
Recent studies from both human and mice cancer models have demonstrated a crucial role for monocytes/macrophages in contributing to cancer progression and disease prognosis. However, since each cancer...
Eligibility Criteria
Inclusion
- Subjects must meet all of the inclusion criteria to participate in this study:
- Diagnosed NPC, RCC, HCC or colorectal cancer patients. (Preoperative histologic diagnosis is not required for RCC and HCC.)
- All stages of disease are eligible.
- Adult patients above 21.
- Ability to provide informed consent.
Exclusion
- Subjects meeting any of the exclusion criteria at baseline will be excluded:
- Active infection.
- Immunocompromised or other active immune disorders.
- Have received chemotherapy or other immunomodulating therapy in the past 6 months.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00979277
Last Update
January 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore, Singapore, 119074